title: [Critical haematuria after prostate biopsies with RIVAROXABAN. Case report].
abstract: Managing patients with new oral anticoagulants in perioperative period is not yet well protocolized. We report a clinical case of a critical haematuria after prostate biopsies to a patient treated with RIVAROXABAN. Monitoring and treatment of the haematuria have been difficult due to the lack of biological control and antidote for this treatment.
authors.affiliation: Service d'urologie, centre hospitalier de Boulogne/Mer, rue Jacques-Monod, 62200 Boulogne-sur-Mer, France. Electronic address: jonathan.olivier-2@etu.univ-lille2.fr.
authors.forename: J
authors.initials: J
authors.lastname: Olivier
authors.forename: R
authors.initials: R
authors.lastname: Yakoubi
authors.forename: S
authors.initials: S
authors.lastname: Gras
authors.forename: G
authors.initials: G
authors.lastname: Van Agt
authors.forename: B
authors.initials: B
authors.lastname: Delepaul
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects*; D001706:Biopsy / Q000009:adverse effects; D016638:Critical Illness; D006417:Hematuria / Q000209:etiology*; D006801:Humans; D008297:Male; D009025:Morpholines / Q000009:adverse effects*; D011467:Prostate / Q000473:pathology*; D000069552:Rivaroxaban; D013876:Thiophenes / Q000009:adverse effects*
chemical_list: D000925:Anticoagulants; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban
keywords: Biopsie de prostate; Haematuria; Hématurie; Prostate biopsy; RIVAROXABAN; Xarelto